Empresa Xenetic Biosciences Inc Nasdaq
Acciones
US9840152063
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Cell-based Therapeutics
100,0
%
| 2 | 100,0 % | 3 | 100,0 % | +48,80 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 2 | 100,0 % | 3 | 100,0 % | +48,80 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 58 | 11/07/16 | |
James Parslow
DFI | Director of Finance/CFO | 59 | 03/04/17 |
Curtis Lockshin
CTO | Chief Tech/Sci/R&D Officer | 64 | 01/03/14 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 58 | 11/07/16 | |
Moshe Mizrahy
BRD | Director/Board Member | 71 | - |
Adam Logal
CHM | Chairman | 46 | 14/08/17 |
Dmitriy Genkin
BRD | Director/Board Member | 56 | 01/01/04 |
Roger Kornberg
BRD | Director/Board Member | 77 | 29/02/16 |
Director/Board Member | 72 | 23/01/14 | |
Director/Board Member | 54 | 19/07/19 | |
James Callaway
BRD | Director/Board Member | 68 | 14/08/17 |
Director/Board Member | 55 | 25/09/19 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 0 | 1 804 394 | 0 | 0 | 80,81 % |
Acción B | 1 | 1 543 385 | 1 247 242 ( 80,81 %) | 2 701 ( 0,1750 %) | |
Acción C | 0 | 970 000 | 0 | 0 |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+9,58 % | 115 mil M | |
+12,41 % | 107 mil M | |
-2,59 % | 21,6 mil M | |
-12,38 % | 22,31 mil M | |
-5,29 % | 19,19 mil M | |
-3,35 % | 18,23 mil M | |
-38,57 % | 17,62 mil M | |
+7,51 % | 14,26 mil M | |
+35,67 % | 12,37 mil M |